Notably, B16-F10 tumors have been shown to promote cachexia characterized by weight loss, skeletal muscle wasting, and adipose tissue loss, which can be further exacerbated by immunostimulatory agents such as STING agonists and ICB (16). Here, STING1 is linked to Cachexia.